Sign up USA
Proactive Investors - Run By Investors For Investors

PreveCeutical Medical Inc upgrades to OTCQB to expand US shareholder base

The index is for early-stage and developing United States and international companies, it said
PreveCeutical Medical Inc upgrades to OTCQB to expand US shareholder base
“We are extremely pleased to be able to upgrade to quote on the OTCQB," the firm said.

Health sciences group PreveCeutical Medical Inc (CSE: PREV, OTCQB: PRVCF) said shares began trading on the OTCQB Venture  Marketplace in the US on September 15.

The index is for early-stage and developing United States and international companies.

“We are extremely pleased to be able to upgrade to quote on the OTCQB.

"This listing will enable us to expand our US shareholder base as well as offer the company’s existing US shareholders a more transparent and efficient platform to obtain quotes and trade PreveCeutical securities," said PreveCeutical’s chairman and chief executive Stephen Van Deventer.

The group is developing innovative preventive therapies using organic and nature identical products and currently has five research and development programs.

These are dual gene therapy for curative and prevention therapies for diabetes and obesity; a Sol-gel platform for nose to brain delivery of medical compounds; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone; and a therapeutic product for treating athletes who suffer from concussions.

The group also sells CELLB9, an immune system booster.

View full PREV profile View Profile

PreveCeutical Medical Inc Timeline

Related Articles

Drugs
May 03 2017
The hybrid pharma services and drug development group has hit some key milestones over this year as trial results are eyed.
Picture of drugs
July 18 2017
Gross profit in the half year to December was up by 34%
Clinical Trial
August 04 2017
The study, codenamed INTEREST, should be wrapped up in the fourth-quarter
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use